Cinpanemab
Product Specifications
UNSPSC Description
Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease[1][2].
Target Antigen
α-synuclein
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cinpanemab.html
Purity
98.82
Solubility
H2O
Smiles
[Cinpanemab]
References & Citations
[1]Lang AE, et, al. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 Aug 4;387(5):408-420. |[2]Teng JS, et, al. Immunotherapies for Parkinson's Disease: Progression of Clinical Development. CNS Neurol Disord Drug Targets. 2021;20(9):802-813.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99356/Cinpanemab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99356/Cinpanemab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2094516-02-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6395779-01 0.1 mL
SYNJ2 (Synaptojanin-2, Synaptic Inositol 1,4,5-trisphosphate 5-phosphatase 2, INPP5H, KIAA0348) (MaxLight 405)
Ask
View Details MBS6395779-02 5x 0.1 mL
SYNJ2 (Synaptojanin-2, Synaptic Inositol 1,4,5-trisphosphate 5-phosphatase 2, INPP5H, KIAA0348) (MaxLight 405)
Ask
View Details